West Pharmaceutical Services names new director
28 July 2022 -

West Pharmaceutical Services, Inc. (NYSE: WST), a US-based global company involved in innovative solutions for injectable drug administration, announced on Wednesday that it has named Stephen Lockhart, MD, Ph.D, as its new director.

Dr Lockhart, is a board-certified anaesthesiologist and is the former chief medical officer (CMO) of Sutter Health. He is the founder and executive sponsor of the Sutter Health Institute for Advancing Health Equity. He has earlier served as the regional CMO for Sutter Health East Bay. He has also held the position of the chief administrative officer at St. Luke's campus of California Pacific Medical Center (CMPC) and medical administrative director of surgical services at CMPC. He serves on the board of directors of Molina Healthcare and the National Research Corporation Health and non-profit board service includes the ECRI Institute, REI, The David and Lucile Packard Foundation, and Parks California.

Paolo Pucci, West lead independent director, said, 'We are pleased to welcome Dr Stephen Lockhart to West's board of directors. As a veteran physician and administrator, his wealth of leadership, experience and knowledge will enhance the impact of West's role to deliver healthcare to millions of patients every day. With Stephen's significant board expertise and passion for improving the well-being and diversity of our communities, we look forward to his contributions as a valuable addition to our board of directors.'